Vietnam-focused private equity firm Mekong Capital said on Monday it has successfully divested the entire 24.99 per cent holding in pharmaceutical major Traphaco JSC for a total consideration of more than $64.5 million.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
